LONDON (Reuters) – Pfizer plans to exit its 32% stake in Haleon, its consumer health joint venture with GSK, after the business is spun off as an independent company in July, GSK said on Wednesday.
Pfizer has a 32% stake in Haleon, which produces Sensodyne toothpaste and Advil painkillers.
In a statement, GSK said Pfizer will exit its investment in a “disciplined manner”.
(Reporting by Natalie Grover in London; Twitter @NatalieGrover; Editing by Josephine Mason)
